SCHEMBL7555797

SCHEMBL7555797

CC1C/C(=N/O)CC(C)(C)C1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 14/20 0.50
NPSR1 Q6W5P4 5/20 0.50
KDM4E B2RXH2 5/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 2/20 0.44
GAA P10253 2/20 0.44
KMT2A Q03164 2/20 0.43
ALOX12 P18054 1/20 0.43
MAPT P10636 5/20 0.43
LMNA P02545 3/20 0.43
RECQL P46063 1/20 0.43
MAPK1 P28482 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.38
PLA2G1B P04054 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17135973 1.00 ALDH1A1 (0.50) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL2735553 1.00 ALDH1A1 (0.50) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL11237755 0.98 ALDH1A1 (0.49) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL11237751 0.98 ALDH1A1 (0.49) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL11342557 0.79 ALDH1A1 (0.37) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL7537547 0.76 ALDH1A1 (0.48) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL7542696 0.76 ALDH1A1 (0.48) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL11206930 0.75 ALDH1A1 (0.47) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL11206934 0.75 ALDH1A1 (0.47) ALDH1A1NPSR1KDM4EHTTTDP1
SCHEMBL1931577 0.75 ALDH1A1 (0.43) ALDH1A1NPSR1KDM4EHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347683-B1 CURABLE PHOTOCHROMIC COMPOSITION TRANSITIONS OPTICAL LTD (IE) 2026-05-06 EP disclosed
EP-4727984-A1 CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING (METH)ACRYLATE, AMINE, AND ISOCYANATE FUNCTIONAL COMPONENTS Transitions Optical, Ltd. (IE) 2026-04-22 EP disclosed
US-12570787-B2 Curable compositions and articles prepared therefrom TRANSITIONS OPTICAL, LTD. (IE) 2026-03-10 US disclosed
US-20250361353-A1 Curable Photochromic Compositions Including Isocyanate and Imine Functional Components TRANSITIONS OPTICAL LTD (IE) 2025-11-27 US disclosed
US-12304991-B2 Photochromic article TRANSITIONS OPTICAL, LTD. (IE) 2025-05-20 US disclosed
US-12240996-B2 Curable photochromic composition including a segmented polymer TRANSITIONS OPTICAL, LTD. (IE) 2025-03-04 US disclosed
EP-3877433-B1 PHOTOCHROMIC ARTICLE TRANSITIONS OPTICAL LTD (IE) 2025-01-08 EP disclosed
WO-2024255988-A1 CURABLE PHOTOCHROMIC COMPOSITIONS INCLUDING (METH)ACRYLATE, AMINE, AND ISOCYANATE FUNCTIONAL COMPONENTS TRANSITIONS OPTICAL, LTD. (IE) 2024-12-19 WO disclosed
US-20240254275-A1 Curable Photochromic Composition TRANSITIONS OPTICAL, LTD. (IE) 2024-08-01 US disclosed
EP-4347683-A1 CURABLE PHOTOCHROMIC COMPOSITION Transitions Optical, Ltd. (IE) 2024-04-10 EP disclosed
WO-2019029794-A1 CURABLE PHOTOCHROMIC COMPOSITION INCLUDING A SEGMENTED POLYMER TRANSITIONS OPTICAL, LTD. (IE) 2019-02-14 WO disclosed
US-9040648-B2 Polymer compositions containing mechanochromic polymers PPG INDUSTRIES OHIO, INC. (US) 2015-05-26 US disclosed
US-8889807-B2 Controlled radical polymerization initiators PPG INDUSTRIES OHIO, INC. (US) 2014-11-18 US disclosed
WO-2014152259-A1 POLYMER COMPOSITIONS CONTAINING MECHANOCHROMIC POLYMERS PPG INDUSTRIES OHIO, INC. (US) 2014-09-25 WO disclosed
US-20130273380-A1 CONTROLLED RADICAL POLYMERIZATION INITIATORS PPG INDUSTRIES OHIO, INC.. 2013-10-17 US disclosed
US-20130274412-A1 POLYMER COMPOSITIONS CONTAINING MECHANOCHROMIC POLYMERS PPG INDUSTRIES OHIO, INC. 2013-10-17 US disclosed
US-6482475-B2 POWDER COATING PPG INDUSTRIES OHIO, INC. 2002-11-19 US disclosed
US-20020012751-A1 Thermosetting compositions containing hydroxy functional polymers prepared by atom transfer radical polymerization BARKAC KAREN A (US) 2002-01-31 US disclosed
US-6319988-B1 LIVING BLOCK POLYMER FROM HYDROXY-FUNCTIONAL UNSATURATED MONOMERS AND OTHER MONOMERS ENDCAPPED WITH SULFONYL HALIDE OR A DIETHYL MALONATE (PREFERABLY A-HALO-SUBSTITUTED); BLOCKED POLYISOCYANATE CROSSLINKING AGENT; LOWER VISCOSITIES PPG INDUSTRIES OHIO, INC. 2001-11-20 US disclosed
WO-2000012579-A1 THERMOSETTING COMPOSITIONS CONTAINING HYDROXY FUNCTIONAL POLYMERS PREPARED BY ATOM TRANSFER RADICAL POLYMERIZATION PPG INDUSTRIES OHIO, INC. (US) 2000-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570787-B2 Curable compositions and articles prepared therefrom EHMT2, EHMT1, BHMT2 ALDH1A1 1039/4885NPSR1 4801/4885KDM4E 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.